HS Code:
Sphygmomanometers (HS Code: 9018.11) are medical instruments used for measuring blood pressure. This category includes both manual and digital devices, as well as their parts and accessories. These instruments are critical in healthcare settings for diagnosing and monitoring conditions like hypertension. The global trade of sphygmomanometers reflects the demand for medical equipment, influenced by factors such as aging populations, increasing prevalence of cardiovascular diseases, and advancements in healthcare infrastructure.
Total Trade Volume
USD 1.2 billion
Data from 2022
Source
United Nations Comtrade Database
Average Rate
5.2%
Highest Rate
12% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-USMCA)
Rising demand for digital sphygmomanometers
Increased trade volume for electronic models due to accuracy and ease of use, particularly in developed markets
2021-2022
Growth in home healthcare monitoring
Boosted exports to households as consumers invest in personal health devices post-COVID-19
2020-2022
Supply chain diversification
Manufacturers shifting production bases to Southeast Asia to mitigate risks from geopolitical tensions and tariffs
2022
The EU implemented stricter regulations for medical devices, including sphygmomanometers, requiring enhanced compliance and certification processes.
May 2021
Increased costs for exporters to the EU but improved product safety and market trust
The US reduced tariffs on certain medical equipment, including sphygmomanometers, as part of trade negotiations to ensure supply during health crises.
March 2022
Boosted imports from China, lowering costs for US healthcare providers
Integration of blood pressure monitoring in smartwatches and wearables has started to compete with traditional sphygmomanometers.
January 2023
Potential decline in demand for standalone devices, pushing manufacturers to innovate